Weekly Spotlight - 27.11.24

Soquelitinib Shows Promise in Treating Lung Disease in Preclinical Trial

Subscribe | Follow us on LinkedIn đź”—

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Soquelitinib Shows Promise in Treating Lung Disease in Mice with Systemic Sclerosis

Soquelitinib, a new drug, has shown promise in treating lung disease associated with scleroderma in mouse studies. It reduced inflammation and fibrosis, improving lung function, offering potential hope for future human treatments for this debilitating aspect of the disease.

Washington Woman Shares Her Struggle with Rare Skin Condition and Raynaud's Disease

A Washington woman shares her personal struggle with scleroderma and Raynaud's disease, highlighting the challenges she faced in diagnosis and treatment, as well as her journey towards managing her symptoms and improving her quality of life. Her story aims to raise awareness and support for those affected by these conditions.

Study Reveals Why Women Are More Prone to Autoimmune Disorders

A recent study explains why women are more likely to develop autoimmune disorders, such as scleroderma, due to differences in immune system regulation and the influence of sex hormones. The findings could lead to better understanding and treatment of these conditions.

 

Nailfold Capillaroscopy: A Vital Tool in Diagnosing Rheumatic Diseases Medical Research 

Nailfold capillaroscopy (NFC) is a valuable diagnostic tool for assessing microvascular damage in systemic sclerosis (SSc) and other connective tissue diseases. It aids early diagnosis, particularly in Raynaud's phenomenon, and helps distinguish between primary and secondary conditions, improving patient outcomes and guiding cardiovascular risk screening.

Health Spotlight’s Systemic Sclerosis is a Contentive publication in the Healthcare division